Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib
Clinical trial NCT00474786 · COMPLETED
Trial details
- NCT number
- NCT00474786
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2012-01-01
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.